Oxford Asset Management’s Yarrow Bioscience YARW Stock Holding History

Oxford Asset Management’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-13	Closed	-$210K	–	2122
2019 Q3	$210K	Sell	13 -6	-32%	-$96.8K	0.01%	1564
2019 Q2	$412K	Buy	19 +10	+111%	+$247K	0.01%	1346
2019 Q1	$268K	Buy	+9	New	+$216K	0.01%	1439
2018 Q3	–	Sell	-5	Closed	-$131K	–	1948
2018 Q2	$131K	Sell	5 -28	-85%	-$1.09M	﹤0.01%	1626
2018 Q1	$4.44M	Buy	+33	New	+$4.01M	0.09%	221

Other funds holding YARW

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Oxford Asset Management's YARW Position: Q4 2019 in Review

Oxford Asset Management sold out of Yarrow Bioscience (YARW) in Q4 2019, closing a stake of 13 shares — an estimated $210K sold.

Oxford Asset Management first reported a position in YARW in Q1 2018 and held it in 5 quarters. The position peaked at $4.44M in Q1 2018. 48 funds tracked by Wall St. Rank hold YARW as of Q4 2019.

Oxford Asset Management reported no remaining Yarrow Bioscience position as of Q4 2019 after selling out during the quarter.
Oxford Asset Management sold 13 Yarrow Bioscience shares in Q4 2019, an estimated $210K.
Oxford Asset Management first reported a position in Yarrow Bioscience in Q1 2018 and held it in 5 quarters.
Oxford Asset Management's Yarrow Bioscience position peaked at $4.44M in Q1 2018.
48 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q4 2019.

Based on Oxford Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.